IN2013MU02206A - - Google Patents
Info
- Publication number
- IN2013MU02206A IN2013MU02206A IN2206MU2013A IN2013MU02206A IN 2013MU02206 A IN2013MU02206 A IN 2013MU02206A IN 2206MU2013 A IN2206MU2013 A IN 2206MU2013A IN 2013MU02206 A IN2013MU02206 A IN 2013MU02206A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutically acceptable
- water
- sycrest
- saphris
- asenapine
- Prior art date
Links
- GMDCDXMAFMEDAG-CHHFXETESA-N (S,S)-asenapine maleate Chemical compound OC(=O)\C=C/C(O)=O.O1C2=CC=CC=C2[C@H]2CN(C)C[C@@H]2C2=CC(Cl)=CC=C21 GMDCDXMAFMEDAG-CHHFXETESA-N 0.000 abstract 2
- 229960005245 asenapine Drugs 0.000 abstract 2
- VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940042084 saphris Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2206MU2013 IN2013MU02206A (fr) | 2013-06-28 | 2014-06-25 | |
| PCT/IB2014/062575 WO2014207664A2 (fr) | 2013-06-28 | 2014-06-25 | Composition pharmaceutique stable d'asénapine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2206MU2013 IN2013MU02206A (fr) | 2013-06-28 | 2014-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02206A true IN2013MU02206A (fr) | 2015-06-12 |
Family
ID=52142775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2206MU2013 IN2013MU02206A (fr) | 2013-06-28 | 2014-06-25 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02206A (fr) |
| WO (1) | WO2014207664A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170007537A1 (en) * | 2014-02-18 | 2017-01-12 | Hetero Research Foundation | Pharmaceutical compositions of asenapine |
| US10085971B2 (en) | 2016-08-22 | 2018-10-02 | Navinta Iii Inc | Pharmaceutical solution of asenapine for sublingual or buccal use |
| US11337932B2 (en) | 2016-12-20 | 2022-05-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| CN110087640A (zh) | 2016-12-20 | 2019-08-02 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| US12329862B2 (en) | 2018-06-20 | 2025-06-17 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN109288800A (zh) * | 2018-10-30 | 2019-02-01 | 天津仁生医药科技有限公司 | 马来酸阿塞那平片及其制备方法 |
| CN109330984A (zh) * | 2018-11-20 | 2019-02-15 | 天津仁生医药科技有限公司 | 一种马来酸阿塞那平舌下片及其制备方法 |
| CN114302716B (zh) * | 2019-10-28 | 2024-09-17 | 久光制药株式会社 | 抑制阿塞那平-n-氧化物的生成的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763476A (en) * | 1994-03-02 | 1998-06-09 | Akzo Noble N.V. | Sublingual or buccal pharmaceutical composition |
| WO2012123325A1 (fr) * | 2011-03-11 | 2012-09-20 | Medichem S.A. | Nouvelles formes cristallines du sel de trans-5-chloro-2-méthyl-2,3,3a,12b-tétrahydro-1h-dibenzo[2,3:6,7] oxépino[4,5-c]pyrrole avec l'acide maléique |
-
2014
- 2014-06-25 WO PCT/IB2014/062575 patent/WO2014207664A2/fr not_active Ceased
- 2014-06-25 IN IN2206MU2013 patent/IN2013MU02206A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014207664A3 (fr) | 2015-04-02 |
| WO2014207664A2 (fr) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MU02206A (fr) | ||
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| WO2013188273A8 (fr) | Composition pharmaceutique ophtalmique topique contenant de l'axitinib | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| WO2014016754A3 (fr) | Compositions pharmaceutiques d'inhibiteur de la pompe à protons | |
| WO2012135615A3 (fr) | Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci | |
| HK1208222A1 (en) | Modified release formulations for oprozomib | |
| CA2863376A1 (fr) | Comprimes gastro-resistants | |
| WO2014033526A9 (fr) | Compositions pharmaceutiques d'étoricoxib | |
| WO2015125152A3 (fr) | Compositions pharmaceutiques d'asénapine | |
| WO2015002755A3 (fr) | Composés pour le traitement du paludisme | |
| UA105285C2 (uk) | Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання | |
| WO2014125504A3 (fr) | Compositions pharmaceutiques de fébuxostat | |
| WO2017034242A3 (fr) | Nouveau dérivé de catéchol et composition pharmaceutique le comprenant | |
| WO2017098533A3 (fr) | Procédé de préparation de lisdexamphétamine | |
| MX370184B (es) | Composición farmacéutica que comprende fingolimod. | |
| WO2016165205A8 (fr) | Nouvel inhibiteur de kinase bcr-abl | |
| HK1206269A1 (en) | Pharmaceutical formulation comprising bendamustine | |
| HK1254923A1 (zh) | Shishijimicin a及其类似物的全合成 | |
| WO2013114397A3 (fr) | Sel pharmaceutiquement acceptable de brinzolamide et composition de celui-ci | |
| WO2013124832A3 (fr) | Composition pharmaceutique à libération contrôlée stabilisée comprenant du gliclazide | |
| WO2012153347A3 (fr) | Composition pharmaceutique d'olanzapine de forme 1 à administration par voie orale | |
| WO2017085733A3 (fr) | Procédé amélioré pour la synthèse de 2,6-xylidine et de ses dérivés | |
| WO2014024013A8 (fr) | Pseudo-uridimycine (pum) et ses dérivés |